Stay updated on Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page.

Latest updates to the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page for the study NCT02753127 on ClinicalTrials.gov now shows a 403 Forbidden error instead of the usual content. This indicates the record is currently inaccessible.SummaryDifference18%

- Check8 days agoChange DetectedA new revision tag, v3.7.0, was added and the previous tag v3.6.6 was removed. This reflects an update to the page version rather than changes to the study information.SummaryDifference0.0%

- Check15 days agoChange DetectedAdded Tel Litwinsky, Israel, 52621 as a study site. Removed Qiryat Krinitzi, Israel, 52621 from the site list.SummaryDifference0.1%

- Check22 days agoChange DetectedQiryat Krinitzi, Israel, 52621 was added to the locations list and Tel Litwinsky, Israel, 52621 was removed. The page revision was updated to v3.6.6.SummaryDifference0.1%

- Check29 days agoChange DetectedA new line '2016 ( U.S. NIH Grant/Contract )' was added to the page, reflecting NIH funding for the study. This expands the funding disclosures associated with the trial.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's content or metadata.SummaryDifference0.0%

Stay in the know with updates to Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Napabucasin Combo With FOLFIRI in Colorectal Cancer Clinical Trial page.